Last reviewed · How we verify
NCT06282302
Effect of Isometric and Aerobic Physical Exercise on Blood Pressure Levels in Hypertensive Elderly People
NA trial testing Group control in Hypertension,Essential in 36 participants. Status unknown.
18 March 2024
Quick facts
| Lead sponsor | Instituto de Cardiologia do Rio Grande do Sul |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 36 |
| Start date | 20 January 2024 |
| Primary completion | 18 March 2024 |
| Estimated completion | 30 April 2024 |
| Sites | 1 location across Brazil |
Drugs / interventions tested
- Group control
- Isometric Exercise
- Aerobic Exercise — full drug profile →
Conditions studied
- Hypertension,Essential — all drugs for Hypertension,Essential →
- Hypertension — all drugs for Hypertension →
Sponsor
Instituto de Cardiologia do Rio Grande do Sul — full company profile →
Who can join
Adults 60 to 75, any sex, with Hypertension,Essential or Hypertension. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Introduction: Adequate blood pressure control is necessary to reduce the risk of mortality from cardiovascular events. The effects of aerobic exercise on systemic arterial hypertension are already well known, however, to date, there is little evidence regarding the effect of an isometric exercise session for the lower limbs on blood pressure levels, especially when performed in elderly hypertensive individuals. Objective: To verify the effect of an isometric or aerobic exercise protocol for the lower limbs on 24-hour ambulatory blood pressure in elderly hypertensive individuals.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06282302
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Group control
Trials testing the same drug.
- NCT05362071 — Remotely Supervised Exercise Program in Individuals With Type 2 Diabetes · NA · completed
- NCT02304978 — Prognostic Value of Tissue Factor (TF) in Blood t in Colorectal Cancer in Adults · EARLY_PHASE1 · completed
Other recruiting trials for Hypertension,Essential
Currently open trials in the same condition.
- NCT05067998 — The Benefits of Natural Medicine, Vitamin IV Therapy and Supplements: Maintaining Good Health Through Nature · recruiting
- NCT06461273 — Food is Medicine vs Lifestyle Medicine For Cardiovascular Kidney Metabolic (CKM) Syndrome · NA · active not recruiting
- NCT06205628 — Safety, Tolerability, PK and PD of ADX-850 in Participants With Hypertension · Phase 1 · active not recruiting
- NCT04505618 — Optical Coherence Tomography Angiography in Subjects With Retinal Vascular Disease · NA · recruiting
- NCT04625569 — Genetic of Response to Acute Saline Load Test in Hypertension (Naload) · recruiting
Other Instituto de Cardiologia do Rio Grande do Sul trials
Trials by the same sponsor.
- NCT06917729 — Breathing Exercises of CardioBreath Application on Autonomic and Vascular Function in Hypertension · NA · not yet recruiting
- NCT06497946 — Effects of SlimTrack® Platform on Diet Adherence, Anthropometry and Arterial Stiffness in Postmenopausal Women · NA · recruiting
- NCT06139653 — CardioBreathApp vs IMT in Heart Failure · NA · completed
- NCT03672760 — Inspiratory Muscle Training X CardioBreath App Effects On Vagal Modulation And Pulse Wave Velocity · NA · recruiting
- NCT07147595 — Chronic Effect of Isometric Exercise on Blood Pressure in Patients With Hypertension · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06282302 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Instituto de Cardiologia do Rio Grande do Sul
- Last refreshed: 28 February 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06282302.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing